DEXCOM INC/ US2521311074 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 26.8 bill.USD | - | 49.01 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 1.40 USD | 59.09% |
| EPS Diluted: | 1.30 USD | 58.54% |
| Revenues per Share: | 9.40 USD | 24.78% |
| Book Value per Share: | 5.37 USD | -2.74% |
| Cash Flow per Share: | 1.94 USD | 12.06% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 3,622.30 USD | 24.49% |
| Net Income: | 541.50 USD | 58.70% |
| Operating Cash Flow: | 748.50 USD | - |
| Cash and Cash Equivalents: | 566.30 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 49.01 | 88.64 |
| P/S Ratio: | 7.30 | 13.21 |
| P/BV ratio: | 12.79 | 23.13 |
| P/CF Ratio: | 35.34 | 63.91 |
| PEG: | 0.83 | 1.50 |
| Earnings Yield: | 2.04% | 1.13% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 26.8 bill. USD | 47.84 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 390.6 mill. | |
Profitability
| Gross Profit Margin: | 63.19% |
| EBIT Margin: | 16.50% |
| Net Profit Margin: | 14.95% |
| Return on Equity: | 26.18% |
| Return on Assets: | 8.64% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.36% |
| Liquidity II / Quick Ratio: | 0.99% |
| Liquidity III / Current Ratio: | 2.84% |
| Debt / Equity Ratio: | 1.18% |
| Dynam. Debt / Equity Ratio: | 560.57% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
